Vivos TherapeuticsVVOS
13F holders, Q4 2024 (December 31)20holders −3
2new positions
5sold out
$4.29avg. 13F price*
At the end of Q4 2024, 20 institutions reported holding Vivos Therapeutics Inc. (VVOS) in their 13F filings, down 3 from Q3 2024. 2 opened new positions and 5 sold out. The largest holders were Anson Funds Management LP ($1.0M), Strategic Wealth Investment Group, LLC ($429K) and Geode Capital Management, LLC ($192K).
- Company
- Vivos Therapeutics Inc.
- CUSIP
- 92859E207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.2M |
| Exits | 5 | $204K |
All 13F filers, Q3 2024 → Q4 2024: 302,033 shares bought and 80,263 shares sold, net +221,770 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Anson Funds Management LP | 0.13% | New | 242,583 | $1.0M |
| Strategic Wealth Investment Group, LLC | 0.02% | No change | 100,000 | $429K |
| Geode Capital Management, LLC | 0.00% | Add +55.6% | 44,827 | $192K |
| Cutter & CO Brokerage, Inc. | 0.04% | New | 38,100 | $163K |
| Commonwealth Equity Services, LLC | 0.00% | Add +23.8% | 26,000 | $112K |
| Vanguard Group Inc. | 0.00% | No change | 10,579 | $45K |
| Credit Agricole S A | 0.00% | No change | 2,365 | $10K |
| Osaic Holdings, Inc. | 0.00% | Reduce -56.6% | 593 | $3K |
| Signaturefd, LLC | 0.00% | No change | 547 | $2K |
| UBS Group AG | 0.00% | Add +398.7% | 389 | $2K |
| Group One Trading LLC | 0.00% | No change | 228 | $978 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -90.3% | 161 | $691 |
| Blue Trust, Inc. | 0.00% | No change | 160 | $686 |
| Bank of America Corp. | 0.00% | Add +13.2% | 120 | $515 |
| Morgan Stanley | 0.00% | No change | 74 | $317 |
| Kozak & Associates, Inc. | 0.00% | No change | 49 | $214 |
| Global Retirement Partners, LLC | 0.00% | No change | 23 | $99 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 12 | $51 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 8 | $34 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is VVOS's weight in each manager's 13F, not the share of Vivos Therapeutics Inc. the manager owns.